Fundraising FoxBiotech Startups
11,051 companies tagged Biotech, with their investors and founders.
ImCare Biotech develops diagnostic biomarkers and therapeutic drugs targeting liver diseases, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma. The company conducts research and development in molecular biology and tissue cultures.
0 investors
0 investors
ImmuCell manufactures and sells First Defense, a colostrum-based product that provides passive immunity to newborn calves and lambs against disease, along with a mastitis detection test for dairy cattle.
0 investors
Immunaeon provides cellular banking and cryopreservation services, helping individuals preserve their healthiest cells for potential future medical use. The company serves patients seeking to maintain medical options through cell preservation, with an emphasis on clear communication and privacy protection.
0 investors
0 investors
Immuneering develops Deep Cyclic Inhibitors, a class of oncology medicines designed to pulse dosing faster than cancer's adaptive mechanisms to limit resistance and reduce side effects. The company targets more durable tumor control and improved tolerability for cancer patients.
0 investors
ImmuneSensor Therapeutics is a clinical-stage biotechnology company developing orally available small molecule cGAS inhibitors that target the cGAS-STING innate immune pathway to treat inflammatory and autoimmune diseases. Founded on research from UT Southwestern Medical Center, it advances a pipeline of drug candidates for immune-related conditions.
0 investors
0 investors
0 investors
0 investors
ImmunoMet Therapeutics is a clinical-stage oncology drug developer working to advance lixumistat, a compound targeting oxidative phosphorylation in cancer to address resistance to existing treatments. Founded in 2015 as a spin-off from HanAll Biopharma, the company runs its clinical programs with specialist CROs and partners, including trials at MD Anderson Cancer Center.
0 investors
0 investors
0 investors
0 investors
Immunovus develops software that creates a personal immune "digital twin" to model and forecast an individual's immune trajectory, integrating and interpreting health data such as test results. It targets consumers, clinicians, and pharmaceutical companies, supporting scenario forecasting, personalized clinical trials, drug discovery, and drug repurposing.
0 investors
ImmusanT works on scientific research into the mechanisms of celiac disease, collaborating with investigators from academic and medical research institutions. The company operates in the biotechnology and immunology field focused on this autoimmune condition.
0 investors
0 investors
0 investors
Imunon develops DNA-based immunology technologies designed to treat difficult-to-treat conditions including ovarian cancer and infectious diseases. The company's platforms instruct the immune system to generate targeted therapeutic responses.
0 investors
Imvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
0 investors
Inanovate is a diagnostics company that developed Lyme-ID, an FDA 510(k)-cleared blood test for Lyme disease based on its proprietary Bio-ID technology. The test uses an at-home blood collection kit that is mailed to a CLIA-certified laboratory, with results delivered through an online portal in as little as 24 hours.
0 investors
0 investors
0 investors
0 investors